Travere Therapeutics (TVTX)
(Delayed Data from NSDQ)
$5.74 USD
-0.04 (-0.69%)
Updated Apr 23, 2024 04:00 PM ET
After-Market: $5.68 -0.06 (-1.05%) 7:58 PM ET
5-Strong Sell of 5 5
F Value F Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/02/2024
Time: -- |
3/2024 | $-0.95 | 0.00% |
Earnings Summary
For their last quarter, Travere Therapeutics (TVTX) reported earnings of -$1.16 per share, beating the Zacks Consensus Estimate of $-1.27 per share. This reflects a positive earnings surprise of 8.66%. Look out for TVTX's next earnings release expected on May 02, 2024. For the next earning release, we expect the company to report earnings of -$0.95 per share, reflecting a year-over-year increase of 25.2%.
Earnings History
Price & Consensus
Zacks News for TVTX
Axsome Therapeutics (AXSM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
TVTX: What are Zacks experts saying now?
Zacks Private Portfolio Services